Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neoplastic Syndromes, Hereditary
|
6387 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 8 | 2000 | 2015 | ||||||
Li-Fraumeni Syndrome
|
206 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 3 | 2003 | 2011 | ||||||
Adenocarcinoma of lung (disorder)
|
563 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Adenocarcinoma of pancreas
|
138 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1
|
11 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||||
Brain Neoplasms
|
204 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Carcinogenesis
|
355 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Carcinoma
|
103 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
Cervix Diseases
|
3 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Choroid Plexus Carcinoma
|
11 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Esophageal carcinoma
|
272 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Glioblastoma
|
281 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
High-Grade Squamous Intraepithelial Lesions
|
8 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||
Mammary Neoplasms
|
385 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Neoplasms
|
1644 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||||
Serous cystadenocarcinoma ovary
|
99 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of lung
|
283 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of skin
|
92 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Squamous cell carcinoma of the head and neck
|
348 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
Uterine Carcinosarcoma
|
80 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
ovarian neoplasm
|
757 | 0.724 | 0.360 | 17 | 7674885 | missense variant | C/A;G;T | snv | 0.700 | 0 |